 I announce that the Senator from California (Mrs.  Feinstein) is necessarily absent.    I announce that the Senator from California (Mrs.  Feinstein) is necessarily absent.    I announce that the Senator from California (Mrs.  Feinstein) is necessarily absent.    Madam President, I ask unanimous consent that the text of  the bill be printed in the Record.   There being no objection, the text of the bill was ordered to be  printed in the Record, as follows:                                  S. 2907         Be it enacted by the Senate and House of Representatives of       the United States of America in Congress assembled,       SECTION 1. SHORT TITLE.         This Act may be cited as the ``Medical Device Recall       Improvement Act''.       SEC. 2. REGULATION OF MEDICAL DEVICE RECALLS.         Chapter V of the Federal Food, Drug, and Cosmetic Act (21       U.S.C. 351 et seq.), is amended by inserting after section       518A of such Act the following:       ``SEC. 518B. ELECTRONIC NOTIFICATION FORMAT FOR DEVICE                     RECALLS.         ``(a) Electronic Notification Format for Device Recalls.--        ``(1) In general.--Not later than 2 years after the date of       enactment of the Medical Device Recall Improvement Act, the       Secretary shall publish a form and manner for notifications       of a recall.        ``(2) Content.--The form and manner prescribed by the       Secretary under paragraph (1) shall--        ``(A) be electronic;        ``(B) include mandatory data elements, including--        ``(i) the name of the manufacturer or importer;        ``(ii) the contact information and address of the       manufacturer or importer;        ``(iii) the specific reason for the correction or removal       from the market of the device;        ``(iv) the specific device of the manufacturer or importer       subject to such recall;        ``(v) the unique device identifier of the device,       including, as applicable, the device identifier and any       production identifier;        ``(vi) information for device user facilities and health       professionals with regard to the device and such recall; and        ``(vii) information for patients with regard to the device       and such recall, including--         ``(I) the risk presented by the device; and        ``(II) any action that may be taken by, or on behalf of,       such patients to eliminate or reduce such risk; and         ``(C) include optional data elements as the Secretary       determines to be appropriate.        ``(b) Notifications.--        ``(1) Notifications to the secretary.--        ``(A) In general.--Beginning 180 days after the Secretary       establishes the form and manner for recall notifications       under subsection (a), a manufacturer or importer of a device       shall submit notifications required under section 519(g) to       the Secretary through the electronic notification format       established under subsection (a).        ``(B) Review requirement.--        ``(i) Initial review.--Not later than 2 business days after       receipt of a notification described in subparagraph (A), the       Secretary shall conduct an initial review of such       notification.        ``(ii) Response of the secretary.--Not later than 3       business days after the completion of such review, the       Secretary shall inform the manufacturer or importer of the       information the Secretary determines, through the initial       review under clause (i), should be shared with device user       facilities and health professionals.        ``(2) Notifications to device user facilities and health       professionals.--        ``(A) Initial notifications.--A manufacturer or importer       shall submit notifications to device user facilities and       health professionals through the electronic notification       format established under subsection (a) after an initial       review by the Secretary is completed under paragraph       (1)(B)(i).        ``(B) Subsequent notifications.--A manufacturer or importer       shall provide notifications in addition to those described in       subparagraph (A), as necessary, to device user facilities or       health professionals through the electronic notification       format established under subsection (a).        ``(c) Electronic Database.--The Secretary shall maintain an       electronic database that is publicly accessible,       downloadable, and populated with information regarding device       notifications made under this section.        ``(d) Definitions.--In this section and in section 518C--        ``(1) the term `device user facility' has the meaning given       such term in section 519(b)(6); and        ``(2) the term `recall' has the meaning given such term in       section 518A.        ``(e) Authorization of Appropriations.--For purposes of       conducting activities under this section and hiring personnel       to conduct such activities, there is authorized to be       appropriated $6,700,000 for fiscal year 2024, $1,700,000 for       fiscal year 2025, and $1,000,000 for each of fiscal years       2026 through 2028, to remain available until expended,       without fiscal year limitation.       ``SEC. 518C. PATIENT NOTIFICATION.         ``(a) In General.--The Secretary shall require that any       recall strategy under section 519(g) provides for notice to       patients whom device user facilities and health professionals       treated with the device.        ``(b) Compliance.--In accordance with subsection (a), the       Secretary shall require recall notifications sent from the       manufacturer or importer of the device to--        ``(1) include information for device user facilities and       health professionals about the risks presented by the device       to patients whom device user facilities and health       professionals treated with the device; and        ``(2) instruct such device user facilities and health       professionals to share information under paragraph (1) with       patients whom device user facilities and health professionals       treated with the device.        ``(c) Affected Devices.--Subsection (a) shall apply with       respect to any class I or class II recall for a class II or       class III device that is used outside of device user       facilities and--        ``(1) implanted in the human body;        ``(2) life-sustaining;        ``(3) life-supporting; or        ``(4) used significantly in pediatric populations.        ``(d) Rule of Construction.--Nothing in this section shall       be construed to require device user facilities or health       professionals to provide patient information to the       manufacturer or importer of the device.''.       SEC. 3. PROHIBITED ACTS.         Section 301 of the Federal Food, Drug, and Cosmetic Act (21       U.S.C. 331) is amended by adding at the end the following        ``(jjj) The refusal or failure to submit notifications in       accordance with paragraphs (1) and (2) of section 518B(b).        ``(kkk) The refusal or failure to provide notice in       accordance with section 518C.''.                            ____________________     Madam President, I ask unanimous consent that the text of  the bill be printed in the Record.   There being no objection, the text of the bill was ordered to be  printed in the Record, as follows:                                  S. 2907         Be it enacted by the Senate and House of Representatives of       the United States of America in Congress assembled,       SECTION 1. SHORT TITLE.         This Act may be cited as the ``Medical Device Recall       Improvement Act''.       SEC. 2. REGULATION OF MEDICAL DEVICE RECALLS.         Chapter V of the Federal Food, Drug, and Cosmetic Act (21       U.S.C. 351 et seq.), is amended by inserting after section       518A of such Act the following:       ``SEC. 518B. ELECTRONIC NOTIFICATION FORMAT FOR DEVICE                     RECALLS.         ``(a) Electronic Notification Format for Device Recalls.--        ``(1) In general.--Not later than 2 years after the date of       enactment of the Medical Device Recall Improvement Act, the       Secretary shall publish a form and manner for notifications       of a recall.        ``(2) Content.--The form and manner prescribed by the       Secretary under paragraph (1) shall--        ``(A) be electronic;        ``(B) include mandatory data elements, including--        ``(i) the name of the manufacturer or importer;        ``(ii) the contact information and address of the       manufacturer or importer;        ``(iii) the specific reason for the correction or removal       from the market of the device;        ``(iv) the specific device of the manufacturer or importer       subject to such recall;        ``(v) the unique device identifier of the device,       including, as applicable, the device identifier and any       production identifier;        ``(vi) information for device user facilities and health       professionals with regard to the device and such recall; and        ``(vii) information for patients with regard to the device       and such recall, including--         ``(I) the risk presented by the device; and        ``(II) any action that may be taken by, or on behalf of,       such patients to eliminate or reduce such risk; and         ``(C) include optional data elements as the Secretary       determines to be appropriate.        ``(b) Notifications.--        ``(1) Notifications to the secretary.--        ``(A) In general.--Beginning 180 days after the Secretary       establishes the form and manner for recall notifications       under subsection (a), a manufacturer or importer of a device       shall submit notifications required under section 519(g) to       the Secretary through the electronic notification format       established under subsection (a).        ``(B) Review requirement.--        ``(i) Initial review.--Not later than 2 business days after       receipt of a notification described in subparagraph (A), the       Secretary shall conduct an initial review of such       notification.        ``(ii) Response of the secretary.--Not later than 3       business days after the completion of such review, the       Secretary shall inform the manufacturer or importer of the       information the Secretary determines, through the initial       review under clause (i), should be shared with device user       facilities and health professionals.        ``(2) Notifications to device user facilities and health       professionals.--        ``(A) Initial notifications.--A manufacturer or importer       shall submit notifications to device user facilities and       health professionals through the electronic notification       format established under subsection (a) after an initial       review by the Secretary is completed under paragraph       (1)(B)(i).        ``(B) Subsequent notifications.--A manufacturer or importer       shall provide notifications in addition to those described in       subparagraph (A), as necessary, to device user facilities or       health professionals through the electronic notification       format established under subsection (a).        ``(c) Electronic Database.--The Secretary shall maintain an       electronic database that is publicly accessible,       downloadable, and populated with information regarding device       notifications made under this section.        ``(d) Definitions.--In this section and in section 518C--        ``(1) the term `device user facility' has the meaning given       such term in section 519(b)(6); and        ``(2) the term `recall' has the meaning given such term in       section 518A.        ``(e) Authorization of Appropriations.--For purposes of       conducting activities under this section and hiring personnel       to conduct such activities, there is authorized to be       appropriated $6,700,000 for fiscal year 2024, $1,700,000 for       fiscal year 2025, and $1,000,000 for each of fiscal years       2026 through 2028, to remain available until expended,       without fiscal year limitation.       ``SEC. 518C. PATIENT NOTIFICATION.         ``(a) In General.--The Secretary shall require that any       recall strategy under section 519(g) provides for notice to       patients whom device user facilities and health professionals       treated with the device.        ``(b) Compliance.--In accordance with subsection (a), the       Secretary shall require recall notifications sent from the       manufacturer or importer of the device to--        ``(1) include information for device user facilities and       health professionals about the risks presented by the device       to patients whom device user facilities and health       professionals treated with the device; and        ``(2) instruct such device user facilities and health       professionals to share information under paragraph (1) with       patients whom device user facilities and health professionals       treated with the device.        ``(c) Affected Devices.--Subsection (a) shall apply with       respect to any class I or class II recall for a class II or       class III device that is used outside of device user       facilities and--        ``(1) implanted in the human body;        ``(2) life-sustaining;        ``(3) life-supporting; or        ``(4) used significantly in pediatric populations.        ``(d) Rule of Construction.--Nothing in this section shall       be construed to require device user facilities or health       professionals to provide patient information to the       manufacturer or importer of the device.''.       SEC. 3. PROHIBITED ACTS.         Section 301 of the Federal Food, Drug, and Cosmetic Act (21       U.S.C. 331) is amended by adding at the end the following        ``(jjj) The refusal or failure to submit notifications in       accordance with paragraphs (1) and (2) of section 518B(b).        ``(kkk) The refusal or failure to provide notice in       accordance with section 518C.''.                            ____________________   